Suppr超能文献

住院儿童(EREMI)中药物不良反应与未授权/超说明书用药的关系:一项研究方案。

Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.

机构信息

Neonatal Intensive Care Unit and Neonatology, hôpital Femme-Mère-Enfant, Hospices civils de Lyon, 69500 Bron, France; Department of Pharmacotoxicology, Hospices civils de Lyon, 69003 Lyon, France; UMR 5558, CRNS, LBBE, EMET, Université Lyon, 69008 Lyon, France.

Inserm CIC 1407, EPICIME-Clinical Investigation Center, 69003 Lyon, France.

出版信息

Therapie. 2021 Nov-Dec;76(6):675-685. doi: 10.1016/j.therap.2021.01.057. Epub 2021 Feb 4.

Abstract

INTRODUCTION

To date, few studies have shown a significant association between off-label drug use and adverse drug reactions (ADRs). The main aims of this study is to evaluate the relationship between adverse drug reactions and unlicensed or off-label drugs in hospitalized children and to provide more information on prescribing practice, the amplitude, consequences of unlicensed or off-label drug use in pediatric inpatients.

METHODS

In this multicenter prospective study started from 2013, we use the French summaries of product characteristics in Theriaque (a prescription products guide) as a primary reference source for determining pediatric drug labeling. The detection of ADRs is carried out spontaneously by health professionals and actively by research groups using a trigger tool and patients' electronic health records. The causality between suspected ADRs and medication is evaluated using the Naranjo and the French methods of imputability independently by pharmacovigilance center. All suspected ADRs are submitted for a second evaluation by an independent pharmacovigilance experts.

STRENGTH AND LIMITATIONS OF THIS STUDY

For our best knowledge, EREMI is the first large multicenter prospective and objective study in France with an active ADRs monitoring and independent ADRs validation. This study identifies the risk factors that could be used to adjust preventive actions in children's care, guides future research in the field and increases the awareness of physicians in off-label drug use and in detecting and declaring ADRs. As data are obtained through extraction of information from hospital database and medical records, there is likely to be some under-reporting of items or missing data. In this study the field specialists detect all adverse events, experts in pharmacovigilance centers assess them and finally only the ADRs assessed by the independent committee are confirmed. Although we recruit a high number of patients, this observational study is subject to different confounders.

摘要

简介

迄今为止,很少有研究表明药物标签外使用与药物不良反应(ADR)之间存在显著关联。本研究的主要目的是评估住院儿童中药物不良反应与未获许可或标签外用药之间的关系,并提供更多关于处方实践、儿科住院患者未获许可或标签外用药的幅度和后果的信息。

方法

在这项始于 2013 年的多中心前瞻性研究中,我们使用法国 Theriaque(一种处方产品指南)的产品特征摘要作为确定儿科药物标签的主要参考来源。ADR 的检测由卫生专业人员自发进行,研究小组使用触发工具和患者电子健康记录主动进行。疑似 ADR 与药物之间的因果关系由药物警戒中心独立使用 Naranjo 和法国归因方法进行评估。所有疑似 ADR 均提交给独立的药物警戒专家进行二次评估。

本研究的优势和局限性

据我们所知,EREMI 是法国第一项大型多中心前瞻性和客观研究,具有主动的 ADR 监测和独立的 ADR 验证。这项研究确定了可能用于调整儿童护理中预防措施的风险因素,指导该领域的未来研究,并提高医生对标签外用药和检测和报告 ADR 的认识。由于数据是通过从医院数据库和病历中提取信息获得的,因此可能存在一些项目漏报或数据缺失。在这项研究中,现场专家检测所有不良事件,药物警戒中心的专家对其进行评估,最后只有独立委员会评估的 ADR 才得到确认。尽管我们招募了大量患者,但这项观察性研究仍受到不同混杂因素的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验